Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: J Genet Couns. 2017 Nov 22;27(3):709–722. doi: 10.1007/s10897-017-0172-x

Figure 1.

Figure 1

Figure 1

Figure 1

Participant anxiety (a), depression (b) and health worry (c) scores at baseline, 1 month and 12 months post-results disclosure (ES groups) and post-enrollment (No ES group) stratified by study group (Exome sequencing with personal disease risk (ES w/PDR), ES w/o PDR and No ES). Individual participant scores are shown by grey lines with overlaid means scores at each time point shown by a black line. The dotted line indicates the threshold for diagnosis of anxiety or depression.

Abbreviations: exome sequencing (ES) personal disease risk (PDR)